Discovery and study of biomarkers using omics technologies

Advanced multi-omics analysis and data integration for biomarker Discovery and characterisation

Need for advanced solutions for biomarker identification

In a context where personalised medicine, early prevention and therapeutic efficiency have become global priorities, demand for omics studies for biomarker identification is growing rapidly.


The pharmaceutical, biotechnology, food and clinical sectors are increasingly seeking tools capable of offering a deep and multi-capability understanding of biological systems. Technologies such as genomics, transcriptomics, proteomics and metabolomics make it possible to detect predictive, diagnostic and prognostic molecular signatures with unprecedented precision.

Our solution

  • LC-MS/MS for in-depth analysis of metabolic and protein profiles.
  • LC-MS/MSNext-generation sequencing (NGS) to study gene expression, microbiota and other levels of biological regulation.